High-intensity focused ultrasound (HIFU) is an increasingly used, locally ablative therapy option in localized prostate cancer (PCa). Multiparametric MRI (mpMRI) is currently used for tumor ...

Nuclear medicine has undergone a remarkable transformation, with both diagnostic and therapeutic applications expanding at an unprecedented pace. This progress is rooted in fundamental discoveries by ...

Radiotheranostics refers to dual diagnostic–therapeutic capacity that allows for precision medicine at an unprecedented level, reducing collateral toxicity and improving patient outcomes ([1][1]). In ...

Journal of Nuclear Medicine November 2025, jnumed.125.270404; DOI: https://doi.org/10.2967/jnumed.125.270404 ...

Journal of Nuclear Medicine November 2025, jnumed.125.270481; DOI: https://doi.org/10.2967/jnumed.125.270481 ...

Journal of Nuclear Medicine November 2025, jnumed.125.270710; DOI: https://doi.org/10.2967/jnumed.125.270710 ...

Journal of Nuclear Medicine November 2025, jnumed.125.269782; DOI: https://doi.org/10.2967/jnumed.125.269782 ...

Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177 Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine Prediction of 177 ...

Today's medical imaging technologies are expected to furnish anatomic, physiologic, molecular, and genomic information for accurate disease diagnosis, prediction of treatment response, and development ...

High expression of prostate-specific membrane antigen (PSMA) is not limited to prostate cancer but can be found in other tumor entities, such as hepatocellular carcinoma (HCC), and could possibly be ...

Journal of Nuclear Medicine November 2025, jnumed.125.271344; DOI: https://doi.org/10.2967/jnumed.125.271344 ...

Journal of Nuclear Medicine November 2025, jnumed.125.271295; DOI: https://doi.org/10.2967/jnumed.125.271295 The timeline montage shown in Figure 1 highlights some of ...